Details

Project TitleRhinovirus-C Peptide for Development of Vaccines and Antivirals
Track CodeP160341US02
Websitehttp://www.warf.org/technologies/summary/P160341US02.cmsx
Short DescriptionHuman rhinoviruses (species A, B and C) are responsible for the majority of upper respiratory tract infections (like the common cold) and many infections of the lower respiratory tract as well.

Rhinovirus C species (RV-C) was discovered in 2006 and is of special interest because it can cause more severe illnesses in children and is closely associated with asthma exacerbations. However, no vaccines or effective antiviral treatments for RV-C currently are available.\r\n\r\nUW–Madison researchers have identified novel immunogenic peptides from RV-C that are useful targets for therapeutic antibodies.

Recent advances in microscopy enabled the researchers to determine (with atomic resolution) the structure of an RV-C strain, both in its full, infectious form and as native empty particles. The structures highlighted immunogenic surfaces that could be used to design antivirals or vaccines against RV-C.
AbstractThe Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing an immunogenic peptide from rhinovirus-C, as well as related vaccines and therapeutic compounds.
 
Tagsbiotechnology, Drug Discovery, rhinovirus C
 
Posted DateJul 19, 2017 9:24 PM

Advantages

  • Provides – for the first time – an effective target for vaccines or antivirals against RV-C

Potential Applications

  • Prevention and treatment of RV-C infection, including infection associated with childhood asthma and adult respiratory problems

Additional Information

P140382US02 describes an efficient, cost-effective method of propagating RV-C.

http://www.warf.org/technologies/summary/P140382US02.cmsx



Liu Y., Hill M.G., Klose T., Chen Z., Watters K., Bochkov Y.A., Jiang W., Palmenberg A.C. and Rossmann M.G. 2016. Atomic Structure of a Rhinovirus C, a Virus Species Linked to Severe Childhood Asthma. Proc. Natl. Acad. Sci. USA. 113, 8997-9002.

Liu Y., Hill M.G., Klose T., Chen Z., Watters K., Bochkov Y.A., Jiang W., Palmenberg A.C. and Rossmann M.G. 2016. Atomic Structure of a Rhinovirus C, a Virus Species Linked to Severe Childhood Asthma. Proc. Natl. Acad. Sci. USA. 113, 8997-9002.



P160050US02 features a mutated RV-C strain that achieves maximum replication, virus yields and cytopathic effect in HeLa-E8 cells.

http://www.warf.org/technologies/summary/P160050US02.cmsx

Contact Information

TTO Home Page: http://www.warf.org



Name : Jennifer Gottwald

Title : Director of Licensing

Department : Licensing

Email : jennifer@warf.org

Phone : 608-960-9854

Address : 614 Walnut Street, 13th floor, Madison, WI 53726

Principal Investigator

Name : Ann Palmenberg

Department : Institute for Molecular Virology



Name : Kelly Watters

Department : Institute for Molecular Virology



Name : Marchel Hill

Department : Institute for Molecular Virology



Name : Michael Rossman

Department : Purdue University



Name : Yue Liu

Department : Purdue University

Intellectual Property

Patent Number : 10,428,116

Patent Title : RHINOVIRUS C IMMUNOGENIC PEPTIDES

Patent Application Date : Apr 19, 2017

Patent Publication Date : Oct 26, 2017

Patent Issue Date : Oct 1, 2019

Patent Link : http://www.warf.org/documents/ipstatus/P160341US02.PDF